Compare ABCL & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | FBIN |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | 2020 | 2011 |
| Metric | ABCL | FBIN |
|---|---|---|
| Price | $9.66 | $46.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 20 |
| Target Price | $18.69 | ★ $49.29 |
| AVG Volume (30 Days) | 2.8M | ★ 2.8M |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.20% |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | $75,128,000.00 | ★ $4,463,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.74 | N/A |
| P/E Ratio | ★ N/A | $109.93 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $32.34 |
| 52 Week High | $14.98 | $64.84 |
| Indicator | ABCL | FBIN |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 56.01 |
| Support Level | $3.45 | $36.96 |
| Resistance Level | $12.91 | $53.86 |
| Average True Range (ATR) | 0.84 | 2.15 |
| MACD | -0.22 | -0.30 |
| Stochastic Oscillator | 2.41 | 30.15 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.